Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
- Scientific Advisory Board member @DrAnneCarpenter has been with Recursion since the early days — but how she got co… https://t.co/K63AZnVs1x
- This weekend our teams joined the #neurofibromatosis community to participate at the Steps to Cure NF Walk in Hartf… https://t.co/ivOXYYbFtl
- On the latest episode of the BIOS Podcast from @AlixVentures, @RecursionChris & @DaphneKoller of @insitro share how… https://t.co/9P8wzWpxAg